levothyroxine sodium (Eton Pharmaceuticals)

N/A

Report date: 2025/10/24 16:19:00

Base Information

Drug Namelevothyroxine sodium (Eton Pharmaceuticals)
Drug Alias Namethyroxinereformulation of an undisclosed approved drug (Eton Pharmaceuticals)LevothyroxineET-103
ClassificationSmall molecules
Mechanisms of ActionThyroid hormone receptor agonists
TargetsThyroid hormone receptor
Therapy Area/IndicationsEndocrine System Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Clinical)
Highest Status in ChinaN/A
Originator CompaniesEton Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesEton Pharmaceuticals Inc
Active IndicationsN/A
Inactive IndicationsEndocrine System Diseases

Other Information

ATC CodeN/A
Related LinksN/A